Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IMNM | IMMUNOME INC | Healthcare | 1,126,210.0 | $24.2M | 3.36% | NEW | — | $21.48 | +2.5% |
| 2 | — CALL | UNIQURE NV | — | 720,800.0 | $17.2M | 2.40% | NEW | — | $23.93 | — |
| 3 | PFE | PFIZER INC | Healthcare | 419,134.0 | $10.4M | 1.45% | NEW | — | $24.90 | +3.4% |
| 4 | GH | GUARDANT HEALTH INC | Healthcare | 91,914.0 | $9.4M | 1.30% | NEW | — | $102.14 | -3.4% |
| 5 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 187,737.0 | $6.2M | 0.85% | NEW | — | $32.76 | +130.9% |
| 6 | — | SOLENO THERAPEUTICS INC | — | 117,485.0 | $5.4M | 0.76% | NEW | — | $46.30 | — |
| 7 | — CALL | KALVISTA PHARMACEUTICALS INC | — | 290,600.0 | $4.7M | 0.65% | NEW | — | $16.15 | — |
| 8 | FULC | FULCRUM THERAPEUTICS INC | Healthcare | 394,650.0 | $4.5M | 0.62% | NEW | — | $11.31 | -37.1% |
| 9 | — CALL | FULCRUM THERAPEUTICS INC | — | 391,900.0 | $4.4M | 0.62% | NEW | — | $11.31 | — |
| 10 | — | SURROZEN INC | — | 157,323.0 | $3.6M | 0.49% | NEW | — | $22.60 | — |
| 11 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 398,167.0 | $3.4M | 0.47% | NEW | — | $8.46 | +51.1% |
| 12 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 36,124.0 | $3.0M | 0.41% | NEW | — | $81.88 | -20.4% |
| 13 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 34,589.0 | $2.7M | 0.37% | NEW | — | $77.81 | +8.6% |
| 14 | NXTC | NEXTCURE INC | Healthcare | 176,057.0 | $2.5M | 0.35% | NEW | — | $14.19 | -31.4% |
| 15 | CTMX | CYTOMX THERAPEUTICS INC | Healthcare | 385,974.0 | $1.6M | 0.23% | NEW | — | $4.26 | -11.3% |
| 16 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 357,387.0 | $1.4M | 0.20% | NEW | — | $4.00 | -1.5% |
| 17 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 42,052.0 | $1.0M | 0.14% | NEW | — | $24.81 | +37.1% |
| 18 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 100,000.0 | $750K | 0.10% | NEW | — | $7.50 | +30.8% |
| 19 | ADGM | ADAGIO MED HLDGS INC | Healthcare | 515,384.0 | $536K | 0.07% | NEW | — | $1.04 | -17.3% |
| 20 | — | PALISADE BIO INC | — | 102,108.0 | $240K | 0.03% | NEW | — | $2.35 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%